Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Triage for selection to colonoscopy?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The EURECCA project: Data items scored by European colorectal cancer audit registries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Clinical outcome in 520 consecutive Danish rectal cancer patients treated with short course preoperative radiotherapy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Tomografía computarizada para el diagnóstico de la apendicitis aguda en adultos

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Computed tomography for diagnosis of acute appendicitis in adults

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The COLOFOL trial: study design and comparison of the study population with the source cancer population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Monika Egenvall
  • Anna Martling
  • Katalin Veres
  • Erzsébet Horváth-Puhó
  • Peer Wille-Jørgensen
  • Sune Høirup Petersen
  • Søren Laurberg
  • Henrik Toft Sørensen
  • Ingvar Syk
  • COLOFOL Study Group
  • Per Jess (Medlem af forfattergruppering)
Vis graf over relationer

BACKGROUND: Patients with colorectal cancer were examined to determine (1) whether elevated carcinoembryonic antigen (CEA) levels, either before treatment or after surgery, was associated with an increased risk of overall or colorectal cancer-specific mortality or recurrence, and (2) whether high intensity follow-up would benefit those patients.

MATERIALS AND METHODS: Post-hoc analysis based on 2509 patients that underwent surgery for colorectal cancer, stage II or III, in the COLOFOL randomized trial with 5-year follow-up. Serum CEA levels were ascertained before treatment and one month after surgery. Follow-up examinations included computed tomography of the thorax and abdomen and serum CEA sampling. Patients were randomized to examinations at either 6, 12, 18, 24, and 36 months (high-intensity group) or at 12 and 36 months after surgery (low-intensity group). Levels of CEA >5 μg/l were defined as elevated.

RESULTS: Elevated CEA levels before treatment were associated with increased risk of recurrence (hazard ratio [HR], 1.49; 95% confidence interval [CI]: 1.22-1.83), colorectal cancer-specific mortality (HR, 1.44; 95% CI: 1.08-1.91), and overall mortality (HR, 1.38; 95% CI: 1.07-1.78). Elevated CEA levels after surgery were associated with increased colorectal cancer-specific mortality (HR, 1.68; 95% CI: 1.08-2.61) and overall mortality (HR, 1.79; 95% CI: 1.22-2.63). The intensity of the follow-up regimen had no effect on 5-year outcomes in patients with elevated CEA levels.

CONCLUSION: Both pre-treatment and post-surgery elevated serum CEA levels were associated with increased overall and cancer-specific mortality. Intensified follow-up showed no benefit over low-intensity follow-up in this high-risk group of patients with elevated CEA levels.

OriginalsprogEngelsk
TidsskriftEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Vol/bind47
Udgave nummer8
Sider (fra-til)2053-2059
Antal sider7
ISSN0748-7983
DOI
StatusUdgivet - aug. 2021

ID: 66403907